OpenLB
Open Library of Bioscience
Advanced Search
Cells
03 21, 2024;13 (6):

Pros and Cons of Cryopreserving Allogeneic Stem Cell Products.

Caterina Giovanna Valentini, Claudio Pellegrino, Luciana Teofili
Author Information
  1. Caterina Giovanna Valentini: Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, 00168 Rome, Italy. ORCID
  2. Claudio Pellegrino: Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, 00168 Rome, Italy. ORCID
  3. Luciana Teofili: Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, 00168 Rome, Italy. ORCID
PMID: 38534396 DOI: 10.3390/cells13060552

Abstract

The COVID-19 pandemic has precipitously changed the practice of transplanting fresh allografts. The safety measures adopted during the pandemic prompted the near-universal graft cryopreservation. However, the influence of cryopreserving allogeneic grafts on long-term transplant outcomes has emerged only in the most recent literature. In this review, the basic principles of cell cryopreservation are revised and the effects of cryopreservation on the different graft components are carefully reexamined. Finally, a literature revision on studies comparing transplant outcomes in patients receiving cryopreserved and fresh grafts is illustrated.

Keywords

COVID-19 allogeneic hematopoietic stem cell transplant cryopreservation

References

  1. Am J Hematol. 2021 Feb 1;96(2):169-171 [PMID: 33206414]
  2. Biol Blood Marrow Transplant. 2020 Dec;26(12):2181-2189 [PMID: 32717432]
  3. Vox Sang. 2008 May;94(4):351-7 [PMID: 18179677]
  4. Biol Blood Marrow Transplant. 2018 Dec;24(12):e31-e35 [PMID: 30142418]
  5. Clin Vaccine Immunol. 2009 Aug;16(8):1176-86 [PMID: 19515870]
  6. Transplant Cell Ther. 2021 Dec;27(12):1022.e1-1022.e6 [PMID: 34571211]
  7. Int J Hematol. 2023 Mar;117(3):428-437 [PMID: 36378406]
  8. Transfusion. 2009 Feb;49(2):354-61 [PMID: 18980622]
  9. Bone Marrow Transplant. 2005 Oct;36(7):601-3 [PMID: 16044141]
  10. Bone Marrow Transplant. 2023 Dec;58(12):1348-1356 [PMID: 37673982]
  11. Bull Exp Biol Med. 2007 Apr;143(4):535-8 [PMID: 18214317]
  12. Cryobiology. 2018 Aug;83:40-47 [PMID: 29908946]
  13. Cryobiology. 2020 Jun;94:9-17 [PMID: 32247742]
  14. Blood Adv. 2021 Feb 9;5(3):861-871 [PMID: 33560397]
  15. Bone Marrow Transplant. 1999 Mar;23(5):497-503 [PMID: 10100565]
  16. F1000Res. 2018 Nov 5;7:1746 [PMID: 31489176]
  17. Bone Marrow Transplant. 2022 Oct;57(10):1531-1538 [PMID: 35804055]
  18. Vox Sang. 2011 Oct;101(3):255-75 [PMID: 21923889]
  19. Sci Transl Med. 2017 Mar 1;9(379): [PMID: 28251904]
  20. Blood Adv. 2021 Dec 14;5(23):5140-5149 [PMID: 34581754]
  21. Blood Adv. 2020 Sep 8;4(17):4147-4150 [PMID: 32886750]
  22. Int Immunopharmacol. 2013 Jul;16(3):371-5 [PMID: 23428908]
  23. J Immunol Methods. 2000 Jun 23;240(1-2):69-78 [PMID: 10854602]
  24. Cytotherapy. 2023 Aug;25(8):877-884 [PMID: 37178096]
  25. Science. 1970 May 22;168(3934):939-49 [PMID: 5462399]
  26. Sci Rep. 2020 Aug 12;10(1):13605 [PMID: 32788637]
  27. BMC Immunol. 2016 Mar 15;17:6 [PMID: 26979060]
  28. Bone Marrow Transplant. 2018 Mar;53(3):274-280 [PMID: 29269805]
  29. Cryobiology. 2017 Dec;79:65-70 [PMID: 28863950]
  30. JAMA. 1965 Sep 6;193:796-804 [PMID: 14329978]
  31. RSC Med Chem. 2023 Sep 5;14(10):2058-2067 [PMID: 37859712]
  32. Transfus Apher Sci. 2023 Dec;62(6):103821 [PMID: 37775358]
  33. Bone Marrow Transplant. 2014 Apr;49(4):469-76 [PMID: 24076548]
  34. Cytotherapy. 2016 Oct;18(10):1325-31 [PMID: 27491794]
  35. Eur J Haematol. 2022 Jan;108(1):61-72 [PMID: 34606661]
  36. In Vitro Cell Dev Biol Anim. 2000 Apr;36(4):262-70 [PMID: 10852352]
  37. Cytotherapy. 2020 May;22(5):291-300 [PMID: 32220549]
  38. Regen Med. 2020 Mar;15(3):1463-1491 [PMID: 32342730]
  39. Cell Transplant. 2021 Jan-Dec;30:9636897211036004 [PMID: 34328022]
  40. Biol Blood Marrow Transplant. 2020 Jul;26(7):1312-1317 [PMID: 32283185]
  41. Cytotherapy. 2009;11(3):341-55 [PMID: 19308771]
  42. Mol Ther. 2019 Jul 3;27(7):1275-1285 [PMID: 31178392]
  43. Sci Rep. 2019 Mar 15;9(1):4641 [PMID: 30874586]
  44. Cryobiology. 2010 Feb;60(1):11-22 [PMID: 19538955]
  45. Biopreserv Biobank. 2017 Apr;15(2):134-141 [PMID: 28332850]
  46. Biol Blood Marrow Transplant. 2004 Feb;10(2):135-41 [PMID: 14750079]
  47. Exp Hematol. 2001 Jan;29(1):114-22 [PMID: 11164112]
  48. Am J Hematol. 2007 Jun;82(6):463-72 [PMID: 17266054]
  49. Transfus Apher Sci. 2007 Feb;36(1):95-101 [PMID: 17236813]
  50. Transfusion. 2003 Jan;43(1):42-9 [PMID: 12519429]
  51. Bone Marrow Transplant. 2020 Nov;55(11):2071-2076 [PMID: 32404975]
  52. Transplant Cell Ther. 2023 Nov;29(11):700.e1-700.e8 [PMID: 37659695]
  53. Biol Blood Marrow Transplant. 2020 Jul;26(7):e161-e166 [PMID: 32389803]
  54. Biol Blood Marrow Transplant. 2007 Oct;13(10):1233-43 [PMID: 17889361]
  55. Blood Adv. 2023 Oct 10;7(19):5982-5993 [PMID: 37036959]
  56. Cytotherapy. 2002;4(6):551-5 [PMID: 12568991]
  57. Transfus Apher Sci. 2022 Feb;61(1):103298 [PMID: 34696981]
  58. Transfusion. 2005 Jul;45(7):1208-13 [PMID: 15987368]
  59. Cell Transplant. 2016;25(7):1247-57 [PMID: 26345294]
  60. Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7738-7743 [PMID: 30936320]
  61. Bone Marrow Transplant. 2014 Jun;49(6):780-5 [PMID: 24686987]
  62. Bone Marrow Transplant. 2015 Jul;50(7):886-91 [PMID: 25665044]
  63. BioDrugs. 2021 Sep;35(5):529-545 [PMID: 34427899]
  64. Cryobiology. 2017 Jun;76:74-91 [PMID: 28428046]
  65. Nat Rev Chem. 2022;6(8):579-593 [PMID: 35875681]
  66. Front Pediatr. 2020 Oct 02;8:570282 [PMID: 33123504]
  67. Transfusion. 1994 Oct;34(10):887-90 [PMID: 7940661]
  68. Transfus Apher Sci. 2016 Jun;54(3):345-55 [PMID: 27216544]
  69. Transplant Cell Ther. 2021 Feb;27(2):133-141 [PMID: 33830022]
  70. Transplant Cell Ther. 2022 Apr;28(4):215.e1-215.e10 [PMID: 35042013]
  71. Am J Hematol. 2021 Mar 1;96(3):E91-E92 [PMID: 33368593]
  72. Cryobiology. 2005 Oct;51(2):165-75 [PMID: 16111670]
  73. Adv Exp Med Biol. 2018;1081:339-354 [PMID: 30288718]
  74. Bone Marrow Transplant. 1993 May;11(5):389-93 [PMID: 8504273]
  75. Cytotherapy. 2021 Jul;23(7):635-640 [PMID: 33423867]
  76. Transfus Med Hemother. 2019 Jun;46(3):188-196 [PMID: 31244587]
  77. J Immunol Methods. 2003 Jul;278(1-2):145-55 [PMID: 12957403]
  78. Transfus Apher Sci. 2023 Aug;62(4):103708 [PMID: 37003931]
  79. Bone Marrow Transplant. 2007 Nov;40(9):831-5 [PMID: 17724443]
  80. Vox Sang. 2008 Feb;94(2):146-52 [PMID: 18028260]
  81. Bone Marrow Transplant. 2008 Jul;42(2):121-8 [PMID: 18391988]
  82. Transfusion. 2017 Jun;57(6):1555-1565 [PMID: 28453219]
  83. Blood. 2015 Mar 12;125(11):1842-3 [PMID: 25766566]
  84. Stem Cells Transl Med. 2024 Jan 12;13(1):30-42 [PMID: 37936262]
  85. PLoS One. 2015 Dec 22;10(12):e0145763 [PMID: 26693907]
  86. Transfusion. 2023 Apr;63(4):774-781 [PMID: 36975826]
  87. Cell Immunol. 2018 Jan;323:1-8 [PMID: 29145997]
  88. Transfusion. 2010 Nov;50(11):2402-12 [PMID: 20573073]
  89. Syst Rev. 2016 Dec 5;5(1):210 [PMID: 27919275]
  90. Transfus Apher Sci. 2020 Aug;59(4):102742 [PMID: 32171686]
  91. In Vitro Cell Dev Biol Anim. 2017 Dec;53(10):855-871 [PMID: 29098516]
  92. J Clin Med. 2022 Jul 15;11(14): [PMID: 35887878]
  93. J Immunol Methods. 2014 Apr;406:1-9 [PMID: 24561308]
  94. Am J Hematol. 2021 Feb 1;96(2):179-187 [PMID: 33108034]
  95. Blood Adv. 2023 Jun 13;7(11):2431-2435 [PMID: 36595453]
  96. Br J Haematol. 1997 Feb;96(2):382-6 [PMID: 9029030]
  97. J Immunol Methods. 2007 Sep 30;326(1-2):93-115 [PMID: 17707394]
  98. Transplant Cell Ther. 2022 Oct;28(10):677.e1-677.e6 [PMID: 35803526]
  99. J Clin Oncol. 2014 Aug 1;32(22):2365-72 [PMID: 24982459]
  100. Cytotherapy. 2022 Mar;24(3):272-281 [PMID: 34654640]
  101. Nat Commun. 2020 Oct 16;11(1):5224 [PMID: 33067467]
  102. Transfusion. 2014 Oct;54(10):2514-22 [PMID: 24964911]
  103. Adv Sci (Weinh). 2019 Jan 27;6(6):1802045 [PMID: 30937270]
  104. Bone Marrow Transplant. 2021 Oct;56(10):2489-2496 [PMID: 34127808]
  105. Cells. 2022 Jan 14;11(2): [PMID: 35053394]
  106. Bone Marrow Transplant. 2021 Aug;56(8):2013-2015 [PMID: 33846562]
  107. Bone Marrow Transplant. 2006 Sep;38(6):399-405 [PMID: 16892075]
  108. Eur J Haematol. 2013 Nov;91(5):448-55 [PMID: 23710624]
  109. Bone Marrow Transplant. 2013 Feb;48(2):243-8 [PMID: 22732701]
  110. Mol Pharm. 2024 Feb 5;21(2):651-660 [PMID: 38230666]
  111. Bone Marrow Transplant. 1993 Feb;11(2):125-31 [PMID: 8435661]
  112. Transplant Cell Ther. 2021 Jun;27(6):507-516 [PMID: 33865804]
  113. Adv Exp Med Biol. 2016;951:1-12 [PMID: 27837550]
  114. Transplant Proc. 2023 Oct;55(8):1799-1809 [PMID: 37210273]

MeSH Term

Humans
Pandemics
Transplantation, Homologous
COVID-19
Hematopoietic Stem Cell Transplantation
Journal Article Review
Article has an altmetric score of 1

Word Cloud

Created with Highcharts 10.0.0cryopreservationtransplantCOVID-19pandemicfreshgraftallogeneicgraftsoutcomesliteraturecellprecipitouslychangedpracticetransplantingallograftssafetymeasuresadoptedpromptednear-universalHoweverinfluencecryopreservinglong-termemergedrecentreviewbasicprinciplesrevisedeffectsdifferentcomponentscarefullyreexaminedFinallyrevisionstudiescomparingpatientsreceivingcryopreservedillustratedProsConsCryopreservingAllogeneicStemCellProductshematopoieticstem

Similar Articles

Cited By